相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Novel Gene Signature-Based Model Predicts Biochemical Recurrence-Free Survival in Prostate Cancer Patients after Radical Prostatectomy
Run Shi et al.
CANCERS (2020)
A Gleason score-related outcome model for human prostate cancer: a comprehensive study based on weighted gene co-expression network analysis
Yongzhi Wang et al.
CANCER CELL INTERNATIONAL (2020)
Development of an autophagy-related gene expression signature for prognosis prediction in prostate cancer patients
Daixing Hu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
Xinyu Geng et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival
Danwen Qian et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer
Constantin Georgescu et al.
BMC CANCER (2019)
Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer
Shangze Li et al.
CANCER RESEARCH (2019)
Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy
Hong Peng et al.
CLINICAL PROTEOMICS (2019)
ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage
Kaimi Li et al.
NEOPLASIA (2019)
Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers
Andrew Kennedy et al.
FRONTIERS IN ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram
Xin Rui et al.
BMC CANCER (2019)
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
L. Schmidt et al.
ANNALS OF ONCOLOGY (2018)
Validation of a 10-gene molecular signature for predicting biochemical recurrence and clinical metastasis in localized prostate cancer
Hatem Abou-Ouf et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma
Huiling He et al.
THYROID (2018)
Establishment of the optimal follow-up schedule after radical prostatectomy
Kazuhiro Matsumoto et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)
Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress
Jennifer Port et al.
CANCER DISCOVERY (2018)
Genes involved in prostate cancer progression determine MRI visibility
Ping Li et al.
THERANOSTICS (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
Lingjian Yang et al.
EBIOMEDICINE (2018)
Interplay between base excision repair protein XRCC1 and ALDH2 predicts overall survival in lung and liver cancer patients
Xin Chen et al.
CELLULAR ONCOLOGY (2018)
Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy
S. Jain et al.
ANNALS OF ONCOLOGY (2018)
Aldehyde Dehydrogenase-2 (ALDH2) Opposes Hepatocellular Carcinoma Progression by Regulating AMP-Activated Protein Kinase Signaling in Mice
Guojun Hou et al.
HEPATOLOGY (2017)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality
B. W. C. Tse et al.
ONCOGENE (2017)
MicroRNA-216b-5p Functions as a Tumor-suppressive RNA by Targeting TPT1 in Pancreatic Cancer Cells
Yu You et al.
JOURNAL OF CANCER (2017)
Integrated genomic analyses identify frequent gene fusion events and VHL inactivation in gastrointestinal stromal tumors
Guhyun Kang et al.
ONCOTARGET (2016)
AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth
Brian R. Hu et al.
PROSTATE (2016)
MiR-301a Regulates E-Cadherin Expression and Is Predictive of Prostate Cancer Recurrence
Robert K. Nam et al.
PROSTATE (2016)
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro et al.
EUROPEAN UROLOGY (2015)
SIGIRR/TIR8, an important regulator of TLR4 and IL-1R-mediated NF-κB activation, predicts biochemical recurrence after prostatectomy in low-grade prostate carcinomas
Tyler M. Bauman et al.
HUMAN PATHOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Translationally Controlled Tumor Protein in Prostatic Adenocarcinoma: Correlation with Tumor Grading and Treatment-Related Changes
Bruno Jim Rocca et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
H. Ross-Adams et al.
EBIOMEDICINE (2015)
Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma
Song Wu et al.
BMC CANCER (2014)
Global Transcriptome Analysis of Formalin-Fixed Prostate Cancer Specimens Identifies Biomarkers of Disease Recurrence
Qi Long et al.
CANCER RESEARCH (2014)
Targeting Hormonal Signaling Pathways in Castration Resistant Prostate Cancer
Marilena Manea et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2014)
Proteomic Signatures of Angiogenesis in Androgen-Independent Prostate Cancer
George S. Karagiannis et al.
PROSTATE (2014)
Overexpression of HepaCAM Inhibits Cell Viability and Motility Through Suppressing Nucleus Translocation of Androgen Receptor and ERK Signaling in Prostate Cancer
Xuedong Song et al.
PROSTATE (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
RCircos: an R package for Circos 2D track plots
Hongen Zhang et al.
BMC BIOINFORMATICS (2013)
Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies
Dejan Knezevic et al.
BMC GENOMICS (2013)
External validation of a Cox prognostic model: principles and methods
Patrick Royston et al.
BMC MEDICAL RESEARCH METHODOLOGY (2013)
The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
Naomi L. Sharma et al.
CANCER CELL (2013)
High NUAK1 expression correlates with poor prognosis and involved in NSCLC cells migration and invasion
Peng Chen et al.
EXPERIMENTAL LUNG RESEARCH (2013)
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer
Mari Kaarbo et al.
PLOS ONE (2013)
Development and validation of a 32-gene prognostic index for prostate cancer progression
Chin-Lee Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Robust rank aggregation for gene list integration and meta-analysis
Raivo Kolde et al.
BIOINFORMATICS (2012)
The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance
Jan S. Moreb et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2012)
Muscle-specific Knock-out of NUAK Family SNF1-like Kinase 1 (NUAK1) Prevents High Fat Diet-induced Glucose Intolerance
Fumika Inazuka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
ARK5 is associated with the invasive and metastatic potential of human breast cancer cells
Xin-Zhong Chang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Targeting TCTP as a New Therapeutic Strategy in Castration-resistant Prostate Cancer
Virginie Baylot et al.
MOLECULAR THERAPY (2012)
Deregulated MYC expression induces dependence upon AMPK-related kinase 5
Lidan Liu et al.
NATURE (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Novel Direct Targets of miR-19a Identified in Breast Cancer Cells by a Quantitative Proteomic Approach
Mamoru Ouchida et al.
PLOS ONE (2012)
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
Salome Gonzalez-Reyes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Characterising the castration-resistant prostate cancer population: a systematic review
M. Kirby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Hedgehog Signaling Protein Expression and its Association With Prognostic Parameters in Prostate Cancer: A Retrospective Study From the View Point of New 2010 Anatomic Stage/Prognostic Groups
Tae-Jung Kim et al.
JOURNAL OF SURGICAL ONCOLOGY (2011)
LMO7 Mediates Cell-Specific Activation of the Rho-Myocardin-Related Transcription Factor-Serum Response Factor Pathway and Plays an Important Role in Breast Cancer Cell Migration
Qiande Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis
Eun Sung Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Decreased expression of LMO7 and its clinicopathological significance in human lung adenocarcinoma
Hiroyuki Nakamura et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2011)
L1 Penalized Estimation in the Cox Proportional Hazards Model
Jelle J. Goeman
BIOMETRICAL JOURNAL (2010)
Molecular sampling of prostate cancer: a dilemma for predicting disease progression
Andrea Sboner et al.
BMC MEDICAL GENOMICS (2010)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
New Roles for the LKB1-NUAK Pathway in Controlling Myosin Phosphatase Complexes and Cell Adhesion
Anna Zagorska et al.
SCIENCE SIGNALING (2010)
Increased susceptibility to spontaneous lung cancer in mice lacking LIM-domain only 7
Miki Tanaka-Okamoto et al.
CANCER SCIENCE (2009)
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2009)
Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model
Carolyn Waugh Kinkade et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles
Kenji Tamura et al.
CANCER RESEARCH (2007)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
Molecular alterations in primary prostate cancer after androgen ablation therapy
CJM Best et al.
CLINICAL CANCER RESEARCH (2005)
Androgen deprivation therapy for prostate cancer
N Sharifi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
ARK5 is a tumor invasion-associated factor downstream of Akt signaling
A Suzuki et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
ARK5 expression in colorectal cancer and its implications for tumor progression
G Kusakai et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: Long-term results
KA Roehl et al.
JOURNAL OF UROLOGY (2004)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy
JF Ward et al.
JOURNAL OF UROLOGY (2003)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Metastatic patterns of prostate cancer:: An autopsy study of 1,589 patients
L Bubendorf et al.
HUMAN PATHOLOGY (2000)
分享论文
